T. Rowe Price Associates
AFMD

T. Rowe Price Associates’s Affimed AFMD Stock Holding History

T. Rowe Price Associates’s Portfolio AFMD Stock Details AFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,621
Closed -$20K – 2890
2023
Q1 		$20K Hold
2,621
– – ﹤0.01% 2858
2022
Q4 		$32K Buy
2,621
+404
+18% +$7.09K ﹤0.01% 2856
2022
Q3 		$46K Buy
2,217
+860
+63% +$23.9K ﹤0.01% 2847
2022
Q2 		$38K Buy
1,357
+320
+31% +$11K ﹤0.01% 2887
2022
Q1 		$45K Buy
+1,037
New +$45.1K ﹤0.01% 2930
2021
Q3 		– Sell
-4,505
Closed -$383K – 2936
2021
Q2 		$383K Buy
4,505
+635
+16% +$57.9K ﹤0.01% 2500
2021
Q1 		$306K Buy
3,870
+201
+5% +$13K ﹤0.01% 2559
2020
Q4 		$214K Sell
3,669
-930
-20% -$43.8K ﹤0.01% 2537
2020
Q3 		$156K Buy
+4,599
New +$174K ﹤0.01% 2470

Other funds holding AFMD

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPSPJS
General Pension Society PZU Joint Stock Warsaw, Poland $654M AUM 55.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates's AFMD Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Affimed (AFMD) in Q2 2023, closing a stake of 2,621 shares — an estimated $20K sold.

T. Rowe Price Associates first reported a position in AFMD in Q3 2020 and held it in 9 quarters. The position peaked at $383K in Q2 2021. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • T. Rowe Price Associates reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 2,621 Affimed shares in Q2 2023, an estimated $20K.
  • T. Rowe Price Associates first reported a position in Affimed in Q3 2020 and held it in 9 quarters.
  • T. Rowe Price Associates's Affimed position peaked at $383K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.